de Gregorio A, Janni W, Friedl TWP, Nitz U, et al. The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C. Br J Cancer 2022 Feb 22. pii: 10.1038/s41416-021-01690.
PMID: 35194193